If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors

$48.00 plus tax (Refund Policy)

Download / Buy Article:


Gargiulo Monachelli G, Meyer M, Rodríguez GE, Garay LI, Sica REP, De Nicola AF, González Deniselle MC. Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors.

Acta Neurol Scand: 2011: 123: 60–67.

© 2010 John Wiley & Sons A/S.

Negative prognostic factors in amyotrophic lateral sclerosis include advanced age, shorter time from disease onset to diagnosis, bulbar onset and rapid progression rate. Objective – 

To compare progesterone (PROG) and cortisol serum levels in patients and controls and ascertain its relationship to prognostic factors and survival. Methods – 

We assessed serum hormonal levels in 27 patients and 21 controls. Results – 

Both hormones were 1.4-fold higher in patients. PROG showed a negative correlation with age, positive correlation with survival and positive trend with time to diagnosis. Increased PROG was observed in spinal onset and slow progression patients. No correlation was demonstrated with cortisol. Conclusion – 

Increased hormonal levels in patients are probably due to hypothalamic–pituitary–adrenal axis activation. Nevertheless, in this preliminary report only PROG correlated positively with factors predicting better prognosis and survival. We hypothesize endogenous PROG and cortisol may be engaged in differential roles, the former possibly involved in a neuroprotective response.

Keywords: amyotrophic lateral sclerosis; cortisol; neuroprotection; progesterone; prognostic factors; survival

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0404.2010.01385.x

Affiliations: 1: Laboratory of Neuroendocrine Biochemistry, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina 2: Neurology Department, J.M. Ramos Mejia Hospital, Buenos Aires, Argentina 3: Department of Science and Technology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina

Publication date: January 1, 2011



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more